Complement factor H mutation associated with membranoproliferative glomerulonephritis with transformation to atypical haemolytic uraemic syndrome

Clinical Kidney Journal

Volumn 6, Issue 2, 2013, Pages 216-219

  Janssen Van Doorn, Karin ^a   Dirinck, Eveline ^a   Verpooten, Gert A ^a,b   Couttenye, Marie M ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

atypical haemolytic uraemic syndrome; complement factor H; MPGN type 1

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; CASE REPORT; COMPLEMENT FACTOR H GENE; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HEMOLYTIC UREMIC SYNDROME; HOMOZYGOSITY; HUMAN; MEDICAL HISTORY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; REVIEW;

EID: 84875754477     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfs190     Document Type: Review

References (19)

1. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 22; 361: 1676-1687
2. Loirat C, Frémeaux-Bacchi V. Atypical haemolytic uremic syndrome. Orphanet J Rare Dis 2011; 6: 60
3. Sethi S, Fervenza FC. Membranoproliferative glomerulone-phritis-a new look at an old entity. N Engl J Med 2012; 366: 1119-1131
4. Loirat C, Noris M, Fremeaux-Bacchi V. Complement and the atypical haemolytic uremic syndrome in children. Pediatr Nephrol 2008; 23: 1957-1972
5. Kavanagh D, Anderson HE. Interpretation of genetic variants of uncertain significance in atypical haemolytic uremic syndrome. Kidney Int 2012; 81: 11-13
6. Kavanagh D, Goodship THJ. Atypical haemolytic Uremic syndrome, genetic basis and clinical manifestations. Hematol-ogy Am Soc Hematol Educ Program 2011; 2011: 15-20
7. Malik TH, Lavin PJ, Goicoechea de Jorge E et al. A hybrid CFHR3-1 gene causes familial C3 glomerulopathy. J Am Soc Nephrol 2012; 23: 1155-1160
8. Delvaeye M, Noris M, De Vriese A et al. Thrombomodulin mutations in atypical haemolytic-uremic syndrome. N Engl J Med 2009; 361: 345-357
9. Hauglustaine D, Vanrenterghem Y, Michielsen OP et al. Oestrogen containing oral contraceptives, decreased prostacyclin production, and haemolytic uraemic syndrome. Lancet 1981; 317: 328-329
10. Karim Y, Masood A. Haemolytic uremic syndrome following measles, mumps and rubella vaccination. Nephrol Dial Transplant 2002; 17: 941-942
11. Sethi S, Fervenza FC, Zhang Y et al. Proliferative glomerulone-phritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol 2011; 6: 1009-1017
12. Sethi S, Fervenza FC. Membranoproliferative glomerulone-phritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 2011; 31: 341-348
13. Servais A, Frémeaux-Bacci V, Lequintrec M et al. Primary glo-merulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic syndrome. J Med Genet 2007; 44: 193-199
14. Cooper M, McGraw ME, Unsworth DJ et al. Familial mesangio-capillary glomerulonephritis with initial presentation as hae-molytic uremic syndrome. Nephrol Dial Transplant 2004; 19: 230-233
15. Skerka C, Licht C, Mengel M et al. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glo-merulonephritis: indications for a disease spectrum and common pathogenic principles. Mol Immunol 2009; 46: 2801-2807
16. Pechtl IC, Kavanagh D, Mcintosh N et al. Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities. J Biol Chem 2011; 286: 11082-11090
17. Servais A, Noël LH, Roumenina LT et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 2012; 82: 454-464
18. Davin J-C, Groothoff J, Gracchi V et al. Long-term renal function under plasma exchange in atypical uremic syndrome. Pediatr Nephrol 2011; 26: 1915-1916
19. Schmidt CQ, Slingsby FC, Richards A et al. Production of biologically active complement factor H in therapeutically useful quantities. Protein Expr Purif 2011; 76: 254-263